Cancer Care Ontario | Action Cancer Ontario

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

688 Results

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2015

Status: Current
ID: PET 2015-1

Oct 2015

Guidelines and Advice

Plerixafor for Autologous Hematopoietic Stem Cell Mobilization and Transplantation for Patients in Ontario

Status: Current
ID: SCT-7

Sep 2015

Guidelines and Advice

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

Status: Current
ID: 2-29
Version: 4

Dec 1969

Guidelines and Advice

Adjuvant Radiotherapy Post-Prostatectomy in T3 or Margin Positive Prostate Cancer

Status: Archived
ID: 3-17
Version: 3

Dec 1969

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2015

Status: Current
ID: PET 2015-2

Dec 1969

Guidelines and Advice

Positron Emission Tomography in Hodgkin Lymphoma Patients Undergoing Curative-Intent Treatment

Status: Current
ID: 27-4

Mar 2016

Guidelines and Advice

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

Guidelines and Advice

Alemtuzumab in Chronic Lymphocytic Leukemia

Status: Education and Information
ID: 6-16 Version 2
Version: 2

Dec 1969

Guidelines and Advice

Preoperative or Postoperative Therapy for Resectable Esophageal Cancer

Status: In-Review
ID: 2-11
Version: 4

Dec 1969

Guidelines and Advice

Pemetrexed Monotherapy for the Maintenance Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Non-Squamous Histology

Status: Archived
ID: CED 21

Jan 2011

Guidelines and Advice

Adjuvant Care for Stage I Ovarian Cancer

Status: Current
ID: 4-13
Version: 3

Mar 2022

Guidelines and Advice

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

Status: Education and Information
ID: 7-12 Version 2
Version: 2

Dec 1969

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2015

Plerixafor for Autologous Hematopoietic Stem Cell Mobilization and Transplantation for Patients in Ontario

Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

Adjuvant Radiotherapy Post-Prostatectomy in T3 or Margin Positive Prostate Cancer

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2015

Positron Emission Tomography in Hodgkin Lymphoma Patients Undergoing Curative-Intent Treatment

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Alemtuzumab in Chronic Lymphocytic Leukemia

Preoperative or Postoperative Therapy for Resectable Esophageal Cancer

Pemetrexed Monotherapy for the Maintenance Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Non-Squamous Histology

Adjuvant Care for Stage I Ovarian Cancer

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

Pages